<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-8-106</article-id><article-id pub-id-type="pmid">18992153</article-id><article-id pub-id-type="doi">10.1186/1471-213X-8-106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Expression of <italic>BLIMP1/PRMT5 </italic>and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Eckert</surname><given-names>Dawid</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dawid.eckert@ukb.uni-bonn.de</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Biermann</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>k.biermann@erasmusmc.nl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Nettersheim</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>daniel.nettersheim@ukb.uni-bonn.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Gillis</surname><given-names>Ad JM</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>a.gillis@erasmusmc.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Steger</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Klaus.Steger@chiru.med.uni-giessen.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>J&#x000e4;ck</surname><given-names>Hans-Martin</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>hjaeck@molmed.uni-erlangen.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Annette M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>annette.mueller@ukb.uni-bonn.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Looijenga</surname><given-names>Leendert HJ</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>l.looijenga@erasmusmc.nl</email></contrib><contrib id="A9" corresp="yes" contrib-type="author"><name><surname>Schorle</surname><given-names>Hubert</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hubert.schorle@ukb.uni-bonn.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Developmental Pathology, Institute of Pathology, University of Bonn, Germany</aff><aff id="I2"><label>2</label>Institute of Pathology, University of Bonn, Germany</aff><aff id="I3"><label>3</label>Department of Urology and Pediatric Urology, University of Giessen, Germany, Institute of Pathology, University of Giessen, Germany</aff><aff id="I4"><label>4</label>Division of Molecular Immunology, Nikolaus-Fiebiger-Zentrum, Universit&#x000e4;t Erlangen-N&#x000fc;rnberg, Erlangen, Germany</aff><aff id="I5"><label>5</label>Department of Pathology Erasmus MC-University Medical Center Rotterdam (Daniel den Hoed Cancer Center) Josephine Nefkens Institute, Rotterdam, the Netherlands</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>7</day><month>11</month><year>2008</year></pub-date><volume>8</volume><fpage>106</fpage><lpage>106</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/8/106"/><history><date date-type="received"><day>1</day><month>4</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Eckert et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Eckert et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Eckert Dawid dawid.eckert@ukb.uni-bonn.de </dc:author><dc:title> Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 8(1): 106-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2008)8:1&#x0003c;106&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Most testicular germ cell tumors arise from intratubular germ cell neoplasia unclassified (IGCNU, also referred to as carcinoma <italic>in situ</italic>), which is thought to originate from a transformed primordial germ cell (PGC)/gonocyte, the fetal germ cell. Analyses of the molecular profile of IGCNU and seminoma show similarities to the expression profile of fetal germ cells/gonocytes. In murine PGCs, expression and interaction of Blimp1 and Prmt5 results in arginine 3 dimethylation of histone H2A and H4. This imposes epigenetic modifications leading to transcriptional repression in mouse PGCs enabling them to escape the somatic differentiation program during migration, while expressing markers of pluripotency.</p></sec><sec><title>Results</title><p>In the present study, we show that BLIMP1 and PRMT5 were expressed and arginine dimethylation of histones H2A and H4 was detected in human male gonocytes at weeks 12&#x02013;19 of gestation, indicating a role of this mechanism in human fetal germ cell development as well. Moreover, BLIMP1/PRMT5 and histone H2A and H4 arginine 3 dimethylation was present in IGCNU and most seminomas, while downregulated in embryonal carcinoma (EC) and other nonseminomatous tumors.</p></sec><sec><title>Conclusion</title><p>These data reveal similarities in marker expression and histone modification between murine and human PGCs. Moreover, we speculate that the histone H2A and H4 arginine 3 dimethylation might be the mechanism by which IGCNU and seminoma maintain the undifferentiated state while loss of these histone modifications leads to somatic differentiation observed in nonseminomatous tumors.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In males aged 15 &#x02013; 34 years, type II testicular germ cell tumors (TGCT), i.e. seminomas and nonseminomas, are the most common malignancies with fatal outcome [<xref ref-type="bibr" rid="B1">1</xref>] accounting for up to 60% of all malignancies in young man. The incidence of this type of cancer has been steadily increasing throughout the last decades [<xref ref-type="bibr" rid="B2">2</xref>]. The tumors arise from a neoplastic precursor, the carcinoma <italic>in situ </italic>(CIS)/<italic>intratubular germ cell neoplasia unclassified </italic>(IGCNU) and develop into seminoma and/or nonseminoma (including embryonal carcinoma, teratomas, yolk sac tumors and choriocarcinomas) [<xref ref-type="bibr" rid="B3">3</xref>]. The IGCNU lesions are believed to arise by delayed or blocked maturation of primordial germ cells (PGC)/gonocytes during early fetal development [<xref ref-type="bibr" rid="B4">4</xref>]. The recently identified markers for IGCNU and seminoma, namely the markers of pluripotency <italic>OCT3/4 </italic>and <italic>NANOG </italic>further support this model [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B10">10</xref>].</p><p>Expression of pluripotency genes is detected in embryonic stem cells (ES) and the inner cell mass of the early embryo. Additionally murine and human ES cells need to be cultured in the presence of factors inhibiting differentiation, although there are species specific differences [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. In PGCs, early gonocytes and IGCNU as well as seminoma lesions some of these markers of pluripotency are expressed, although differences have been reported [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. According to the current model, PGCs actively suppress somatic differentiation programs by epigenetic modifications, a mechanism which might also account for IGCNU and seminoma [<xref ref-type="bibr" rid="B15">15</xref>]. Recent data in mice demonstrate that suppression of somatic differentiation programs in PGCs is mediated by a complex of two proteins, Blimp1 (B-Lymphocyte induced maturation protein-1; PRDM1) and Prmt5 (protein arginine methyltransferase-5). Upon arrival in the genital ridge the PGCs differentiate to become gonocytes and the Blimp1/Prmt5 complex is translocated in the cytoplasm and subsequently, Blimp1 is downregulated. Targeted deletion of Blimp1 leads to loss of PGCs short after specification due to differentiation. The Blimp1-deficient PGCs display an insufficient repression of markers indicative for somatic differentiation such as <italic>HoxB1 </italic>[<xref ref-type="bibr" rid="B16">16</xref>]. Blimp1 is a transcriptional repressor harboring an N-terminal PR-SET domain, 5 zinc-finger domains and an acidic domain at the C-terminus. In murine PGCs the Blimp1/Prmt5 complex mediates symmetrical methylation of histones H2A and H4 at arginine 3 (H2AR3me2s, H4R3me2s), resulting in widespread epigenetic modification leading to transcriptional repression [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>In the present study, we investigated the expression of BLIMP1/PRMT5 during human fetal germ cell development and in testicular germ cell tumors. Analyzing human fetal tissues, we found BLIMP1/PRMT5 colocalized in gonocytes at weeks 12 &#x02013; 19 of pregnancy, supporting a role in human germ cell development. Furthermore BLIMP1/PRMT5 is expressed in IGCNU and seminoma, but downregulated in nonseminomatous GCTs. Since the nuclear localization of BLIMP1 correlated with the presence of the histone modifications H2AR3me2s and H4R3me2, our data help in explaining the undifferentiated/fetal state of IGCNU and seminoma.</p></sec><sec><title>Results</title><sec><title>Normal germ cell development</title><p>Data from murine embryos indicate, that the murine homologs of BLIMP1 and PRMT5, are expressed in PGCs from specification on up to their arrival in the genital ridge [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Short thereafter, these cells differentiate to become gonocytes and the Blimp1/Prmt5 complex is translocated in the cytoplasm and subsequently, Blimp1 is downregulated. In order to test whether human BLIMP1 and PRMT5 are detected in human fetal PGCs/gonocytes, immunohistochemical analyses were performed on human fetal material. On the 12<sup>th </sup>week of pregnancy migrating gonocytes coexpressing PRMT5 and BLIMP1 were detected, (Fig. <xref ref-type="fig" rid="F1">1</xref>, compare A to B, merged in C, arrows). Next, testes from the 19<sup>th </sup>week of pregnancy were analyzed. By this time gonocytes gradually differentiate into prespermatogonia and migrate towards the periphery of the emerging seminiferous tubules to settle down in their niche [<xref ref-type="bibr" rid="B18">18</xref>]. Both BLIMP1 (Fig. <xref ref-type="fig" rid="F2">2A</xref>) and PRMT5 (Fig. <xref ref-type="fig" rid="F2">2B</xref>) were detected at this stage in gonocytes. PRMT5, in contrast to BLIMP1, was detected both in the nucleus and in the cytoplasm. Since the murine Blimp1/Prmt5 complex has been described to mediate symmetrical dimethylation of arginine 3 on histone H2A and/or H4 tails (H2AR3me2s/H4R3me2s) [<xref ref-type="bibr" rid="B17">17</xref>] immunohistochemical analysis to detect this modification was performed (Fig. <xref ref-type="fig" rid="F2">2D</xref>). Co-staining of PRMT5 revealed that the cells displaying high nuclear levels of PRMT5 are in fact positive for the H2AR3me2s/H4R3me2s histone mark (Fig. <xref ref-type="fig" rid="F2">2E</xref> and <xref ref-type="fig" rid="F2">2F</xref>, merged). To further analyze the population of cells expressing BLIMP1 we performed double labeling experiments using BLIMP1 (Figure <xref ref-type="fig" rid="F2">2G</xref>) and the gonocytal markers M2A[<xref ref-type="bibr" rid="B19">19</xref>] (Figure <xref ref-type="fig" rid="F2">2H</xref>). BLIMP1/M2A double positive signals were detected in most gonocytes (Figure <xref ref-type="fig" rid="F2">2I</xref>, arrows). Double labeling for H2AR3me2s/H4R3me2s (Fig <xref ref-type="fig" rid="F2">2K</xref>) combined with M2A (Fig. <xref ref-type="fig" rid="F2">2L</xref>) showed, that the M2A positive gonocytes displayed H2AR3me2s/H4R3me2s modifications (Fig <xref ref-type="fig" rid="F2">2M</xref>). Again, these findings were in accordance with the situation in mice, where the Blimp1 protein is downregulated and the H2AR3me2s/H4R3me2s methylation is gradually lost when germ cells proceed to prespermatogonia [<xref ref-type="bibr" rid="B17">17</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Human fetal gonocytes at 12<sup>th </sup>week of pregnancy</bold>. Sections of human fetal gonocytes at 12<sup>th </sup>week of pregnancy subjected to antibody staining towards BLIMP1 (A), PRMT5 (B) and overlay (C). D and E no primary antibody controls. Arrows indicate exemplary germ cells. Bar = 50 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-8-106-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Human fetal gonocytes at 19<sup>th </sup>week of pregnancy</bold>. Sections of human fetal gonocytes at 19<sup>th </sup>week of pregnancy subjected to antibody staining towards (<bold>A</bold>) BLIMP1, (<bold>B</bold>) PRMT5, (<bold>C</bold>) Merge of BLIMP1 and PRMT5, (<bold>D</bold>) PRMT5, (<bold>E</bold>) methylated H2A/H4, (<bold>F</bold>) merge of PRMT5 and methylated H2A/H4 (<bold>G</bold>) BLIMP1 (<bold>H</bold>) M2A antigen, (<bold>I</bold>) merge of BLIMP1 and M2A, (<bold>K</bold>) methylated H2A/H4, (<bold>L</bold>) M2A, (<bold>M</bold>) merge of methylated H2A/H4 and M2A.</p></caption><graphic xlink:href="1471-213X-8-106-2"/></fig><p>Since the murine Blimp1/Prmt5 complex was specifically detected in early germ cells but not in prespermatogonia[<xref ref-type="bibr" rid="B16">16</xref>] we next asked whether PRMT5, BLIMP1 and dimethylated histone H2A and H4 could be detected in adult human testes. BLIMP1 was detected in the cytoplasm of round spermatids (Fig. <xref ref-type="fig" rid="F3">3A</xref>, arrow) and PRMT5 was found in the nuclei and in the cytoplasm of spermatocytes (Fig. <xref ref-type="fig" rid="F3">3B</xref> arrow) and round spermatids (Fig. <xref ref-type="fig" rid="F3">3B</xref> black arrowhead). H2AR3me2s/H4R3me2s modification is detected in type A spermatogonia (Fig. <xref ref-type="fig" rid="F3">3C</xref> red arrowhead), as well as round and elongated spermatids, (Fig. <xref ref-type="fig" rid="F3">3C</xref> arrow). The cytoplasmatic localization of BLIMP1 in adult testes excludes the functional interaction with PRMT5 and the resulting epigenetic modification. This implicates an alternative mechanism of H2AR3me2s/H4R3me2s modification in adult testes.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Human adult testis</bold>. Sections of normal human adult testis stained for BLIMP1 (<bold>A</bold>), PRMT5 (<bold>B</bold>) methylated and dimethylated histones H2A/H4 (<bold>C</bold>). <bold>(A) </bold>A seminiferous tubule is shown with normal spermatogenesis. Spermatogonia, spermatocytes, and Sertoli cells are devoid of the staining, while nuclear and cytoplasmatic staining occurs in round spermatids (large arrow). (<bold>B</bold>) Staining with PRMT5 antibody shows low expression of PRMT5 in the nuclei of spermatocytes (arrowhead), and strong nuclear staining in round spermatids (large arrow). (<bold>C</bold>) Positive staining with Me H2A/H4 occurs in spermatogonia (red arrowheads) and round spermatids (arrow), but not in spermatocytes. <bold>lu </bold>lumen of the seminiferous tubule; <bold>Le </bold>Leydig Cells.</p></caption><graphic xlink:href="1471-213X-8-106-3"/></fig></sec><sec><title>Type II TGCTs</title><p>We next examined various TGCTs for the presence of BLIMP1/PRMT5 and H2AR3me2s/H4R3me2s. As shown in Figure <xref ref-type="fig" rid="F4">4</xref>, IGCNU show nuclear BLIMP1 staining (Fig. <xref ref-type="fig" rid="F4">4A</xref>), cytoplasmatic PRMT5 staining (Fig. <xref ref-type="fig" rid="F4">4B</xref>) and dimethylation of H2A/H4 (Fig. <xref ref-type="fig" rid="F4">4C</xref>). Seminomas show predominant nuclear BLIMP1 signal (Fig. <xref ref-type="fig" rid="F4">4D</xref>) sparse nuclear PRMT5 signal (Fig. <xref ref-type="fig" rid="F4">4E</xref>) as well as a strong and homogenous signal for H2AR3me2s/H4R3me2s (Fig <xref ref-type="fig" rid="F4">4F</xref>). In embryonal carcinoma, expression of BLIMP1 (Fig. <xref ref-type="fig" rid="F4">4G</xref>) and PRMT5 (Fig. <xref ref-type="fig" rid="F4">4H</xref>) was weak and cytoplasmatic. As expected, histone H2AR3me2s/H4R3me2s methylation (Fig. <xref ref-type="fig" rid="F4">4I</xref>) was barely detectable and heterogeneous. Yolk sac tumors teratomas and choriocarcinomas stained focally and cytoplasmatic for BLIMP1 and PRMT5 (not shown). Focal cytoplasmatic expression of BLIMP1 and PRMT5 was also observed in differentiated parts of teratoma, while chorioncarcinomas were negative for both proteins. A summary of the results of the immunohistochemical studies is given in Table <xref ref-type="table" rid="T1">1</xref>.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Human germ cell tumors</bold>. Sections of neoplastic germ cells of IGCNU (<bold>A-C</bold>), seminoma (<bold>D-F</bold>), embryonal carcinoma (<bold>G-I</bold>) stained for BLIMP1 (<bold>A</bold>, <bold>D</bold>, <bold>G</bold>), PRMT5 (<bold>B</bold>, <bold>E</bold>, and <bold>H</bold>) and methylated histones H2A/H4 (<bold>C</bold>, <bold>F</bold>, <bold>I</bold>). In Figure <bold>A-C </bold>tubules with IGCNU are shown with consistent nuclear expression of BLIMP1 and Me H2A/H4 in neoplastic germ cells (<bold>A</bold>, BLIMP1; <bold>C</bold>, Me H2A/H4). PRMT5 is expressed in the cytoplasm of neoplastic germ cells (<bold>B</bold>). Notice that no expression is present in Sertoli cells. In Figures <bold>D-F </bold>expression in seminomas is presented. Notice the variation of the expression of BLIMP1, being low or moderate in the majority of the cells (<bold>D</bold>). PRMT5 is expressed in the cytoplasm of most seminoma cells, but some neoplastic cells also show nuclear staining (<bold>E</bold>). Figure <bold>F </bold>shows a strong nuclear staining of MeH2A/H4 in most seminoma cells. Size bar is 50 &#x003bc;m. Quantification of the relative expression of BLIMP1 (<bold>K</bold>) and PRMT5 (<bold>L</bold>) normalized to &#x003b2;-Actin and compared to normal testicular tissue. Bars above the graph indicate p-values. (<bold>M, N) </bold>Expression values for BLIMP1 (<bold>M</bold>) and PRMT5 (<bold>N</bold>) from independent Affymetrix expression analyses (as referred in 23). Data are plotted as Log2 (y-axis) after normalization. Abbreviations: Normal testicular tissue (N), IGCNU, seminoma (SE), embryonal carcinoma (EC).</p></caption><graphic xlink:href="1471-213X-8-106-4"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Expression of BLIMP1, PRMT5 and dimethylated histone H4/H2A in normal and neoplastic testicular tissues</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">BLIMP1</td><td align="center">PRMT5</td><td align="center">H4R3me2s/H2Ame2s</td></tr></thead><tbody><tr><td align="left">Normal fetal testis</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Gonocytes</td><td align="center">+++ (n)</td><td align="center">+++ (n,c)</td><td align="center">+++ (n)</td></tr><tr><td align="left">&#x02003;Pre-spermatogonia</td><td align="center">-</td><td align="center">-</td><td></td></tr><tr><td align="left">Normal adult testis (N = 18)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Spermatogonia</td><td align="center">-</td><td align="center">-</td><td align="center">++ (n)</td></tr><tr><td align="left">&#x02003;Pachytene spermatocytes</td><td align="center">-</td><td align="center">+ (n)</td><td align="center">-</td></tr><tr><td align="left">&#x02003;Round spermatids</td><td align="center">+ (n,c)</td><td align="center">++ (n)</td><td align="center">++ (n)</td></tr><tr><td align="left">&#x02003;Elongated spermatids</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="left">Testicular germ cell tumors</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;IGCNU (N = 15)</td><td align="center">+++ (n)<break/>85&#x02013;100%</td><td align="center">+++ (c)<break/>75&#x02013;95%</td><td align="center">+++ (n)<break/>90&#x02013;100%</td></tr><tr><td align="left">&#x02003;Seminoma (N = 20)</td><td align="center">++ (n)<break/>10&#x02013;75%</td><td align="center">++ (n+c)<break/>30&#x02013;85%</td><td align="center">++ (n)<break/>20&#x02013;80%</td></tr><tr><td align="left">&#x02003;Embryonal carcinoma (N = 15)</td><td align="center">+/-(c)*<break/>15&#x02013;80%</td><td align="center">++ (c)<break/>15&#x02013;80%</td><td align="center">(+)*</td></tr><tr><td align="left">&#x02003;Teratoma (N = 5)</td><td align="center">+ (n, c)</td><td align="center">+ (n, c)</td><td align="center">+ (n)</td></tr><tr><td align="left">&#x02003;Chorioncarcinoma (N = 3)</td><td align="center">+ (c)</td><td align="center">-</td><td align="center">-</td></tr></tbody></table><table-wrap-foot><p>N, number of cases; n, nuclear staining; c, cytoplasmatic staining</p><p>+ weak; ++ moderate; +++, strong expression; -, no expression detectable</p><p>*, only single tumor cells were detected as positive.</p></table-wrap-foot></table-wrap><p>In order to quantify the expression of BLIMP1 and PRMT5 we performed RT-PCR analyses on normal testicular tissue as well as on various TGCTs. The RNA levels measured were first normalized to &#x003b2;Actin and then calculated as relative expression with normal testicular tissue (N) set at 1. Expression of BLIMP1 was significantly higher in IGCNU (p = 0.029) containing testicular parenchyma and seminoma (Fig. <xref ref-type="fig" rid="F4">4K</xref>), but not in embryonal carcinoma (EC) (p = 0.16), which was comparable to normal testicular tissue. In contrast, PRMT5 was moderately higher in IGCNU (p = 0.033), while embryonal carcinoma (p = 0,091) and seminoma (p = 0,091) express a similar level of PRMT5 compared to normal testicular tissue (Fig. <xref ref-type="fig" rid="F4">4L</xref>). These data could be confirmed, using a whole genome expression DNA-Array as reported before [<xref ref-type="bibr" rid="B20">20</xref>]. Here, the same pattern was observed (see Fig. <xref ref-type="fig" rid="F4">4M</xref> and <xref ref-type="fig" rid="F4">4N</xref>).</p><p>Finally, we asked whether BLIMP1/PRMT5 and modification of histone H2A and H4 could be detected in TCam-2, a cell line derived from a seminoma patient [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Here, we were able to detect BLIMP1 in the nucleus, PRMT5 in the nucleus and the cytoplasm (Fig. <xref ref-type="fig" rid="F5">5A&#x02013;C</xref>). RT-PCR analyses showed that BLIMP1 and PRMT5 are expressed in TCam-2 cells (Fig. <xref ref-type="fig" rid="F5">5E</xref>) and absent JKT1 cells, in agreement with Affymetrix data (Fig. <xref ref-type="fig" rid="F4">4M</xref> and <xref ref-type="fig" rid="F4">4N</xref>). Of note, the findings on the JKT-1 cell line are in concordance with the conclusion that it is not a seminoma cell line [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Western blot analysis confirmed these results, showing that BLIMP1 and PRMT5, as well as the modified Histones H2A and H4 (Fig. <xref ref-type="fig" rid="F5">5F</xref>) can be detected. Next, we performed a CoIP on extracts from TCam-2 cells and were able to detect a signal for Blimp1 in material immunoprecipitated with PRMT5 antibody (Fig. <xref ref-type="fig" rid="F5">5G</xref>). This result demonstrates for the first time that PRMT-5 and BLIMP-1 interact biochemically.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Analysis of TCam-2 seminoma cell line</bold>. (<bold>A</bold>-<bold>B</bold>) Immunohistochemistry using the antibodies indicated. (<bold>C</bold>) Merge of (<bold>A</bold>) and (<bold>B</bold>). (<bold>D</bold>) Counterstaining with DAPI to detect nuclei. (<bold>E</bold>) RT-PCR cell lines TCam2 and JKT1 as well as Testis detecting expression of the indicated genes. (<bold>F</bold>) Western Blot of protein lysate from TCam2 cells detecting the proteins indicated. (<bold>G</bold>) Co-IP experiment using antibody to PRMT5 for IP and antibody to BLIMP-1 to detect potential interaction. &#x02013; no Antibodyl; + IP using PRMT5 Antibody; Input Control. (<bold>H</bold>) Co-IP experiment using antibody to PRMT7 for IP and antibody to BLIMP-1 to detect potential interaction. &#x02013; no Antibodyl; + IP using PRMT5 Antibody; Input Control. (I-M) Immunohistochemistry using the PRMT7 antibody (I), (<bold>K</bold>) Merge of (<bold>I</bold>) and (<bold>M</bold>), (<bold>L</bold>) Counterstaining with DAPI to detect nuclei, (M) brightfield image. Scale Bar indicates 25 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-8-106-5"/></fig><p>We had shown, that nuclear BLIMP1 and methylated H2A and H4 are expressed in IGCNU and seminoma, yet these cells express either little or cytoplasmic PRMT5 (Fig. <xref ref-type="fig" rid="F4">4A&#x02013;F</xref>). We speculated that another methytransferase cooperating with BLIMP1 might be able to compensate PRMT5 function and help in establishing this methylation pattern. PRMT7 which is like PRMT5 a type II methyltransferase seemed a potential candidate since both PRMT5 and PRMT7 have been demonstrated to mediate symmetric arginine dimethylation of sm Proteins required for the spliceosome [<xref ref-type="bibr" rid="B24">24</xref>]. The CoIP experiment (Fig. <xref ref-type="fig" rid="F4">4H</xref>), demonstrates that BLIMP1 and PRMT7 interact biochemically. In addition PRMT7 shows a strong nuclear signal in TCam-2 cells (Fig. <xref ref-type="fig" rid="F4">4I&#x02013;M</xref>). These results indicate that in germ cell tumors, both PRMT5 and PRMT7 might cooperate with BLIMP1 to establish dimethylation of H2A and H4.</p></sec></sec><sec><title>Discussion</title><p>In this study, we analyzed the expression of the putative inhibitor complex of germ cell differentiation BLIMP1 and PRMT5 on mRNA and protein level and the presence of the resulting repressive histone modifications H2A/H4R3me2s in human fetal and adult germ cells as well as TGCTs. We found BLIMP1 and PRMT5 localized in the nuclei of gonocytes, and the latter also in the cytoplasm, and could show the presence of the resulting dimethylation of H2A/H4 at arginine 3. In IGCNU a strong nuclear signal of BLIMP1 and of H2K3me2s/H4K3me2s was detected, whereas PRMT5 signal was cytoplasmatic in IGCNU and heterogeneous in seminomas.</p><p>The expression in fetal gonocytes in humans described here is in concordance to the observations made in mouse [<xref ref-type="bibr" rid="B17">17</xref>] indicating a conserved role of the nuclear localized BLIMP1/PRMT5 complex between mouse and man. Recently the transcriptional repressor BLIMP1 has been shown to be a crucial determinant of the germ cell lineage in mice [<xref ref-type="bibr" rid="B16">16</xref>]. This Kr&#x000fc;ppel-type zinc-finger containing protein interacts with the arginine methyl-transferase PRMT5 resulting in a symmetrical methylation at arginine 3 of histone H4 and H2A (H4R3me2s/H2Ame2s). The methylation in turn represses transcription[<xref ref-type="bibr" rid="B17">17</xref>] and therefore might be important for suppressing the somatic cell fate and keeping germ cells in a pluripotent state. In fact, in mice Blimp1-deficent germ cells show inconsistent repression of <italic>HoxB1</italic>, a hallmark of germ cell specification and fail to express <italic>Stella </italic>a marker of undifferentiated germ cells [<xref ref-type="bibr" rid="B16">16</xref>]. Also, recent studies showed, that abrogation of the <italic>Drosophila melanogaster </italic>homolog of PRMT5, <italic>Capsuleen/dart5</italic>, is essential for germ cell specification and maintenance [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Interestingly, Blimp1 expression is lost in PGCs which are cultured in the presence of basic FGF and LIF [<xref ref-type="bibr" rid="B15">15</xref>] and gradually become embryonic germ cells [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. Hence the BLIMP1/PRMT5 interaction resulting in H2A/H4 modification might lead to repression of premature differentiation during human fetal germ cell development. As a consequence prolonged expression of BLIMP1/PRMT5 could result in persistence of undifferentiated gonocytes into adulthood.</p><p>It is believed that those persisting gonocytes give rise to IGCNU the common precursor lesion of all type II TGCTs [<xref ref-type="bibr" rid="B4">4</xref>]. Indeed, we detected BLIMP1 protein and the characteristic modification of histones H2A and H4 not only in gonocytes but also in IGCNU and in seminoma supporting a PGC/gonocyte origin of IGCNU and therefore GCT [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. PRMT5 however, is not detectable in nuclei of IGCNU, and displays only a sparse nuclear localization in seminoma cells. We found that another type II protein arginine methyltransferase, PRMT7 is expressed in TCAM2 seminoma cells and that PRMT7 interacts with BLIMP1 as well. So we speculate that in IGCNU and seminoma, BLIMP1 recruits PRMT7 to compensate for the lack of nuclear PRMT5 to mediate H2A and H4 dimethylation.</p><p>Upon progression of IGCNU to nonseminomas signal intensity of BLIMP1 decreased and subcellular localization changed. As a consequence, H2A/H4 modification decreased and became heterogeneous in nonseminomas. Hence, the loss of the repressive histone modifications allows further uncontrolled differentiation observed in nonseminomas.</p></sec><sec><title>Conclusion</title><p>Taken together we propose the following model for development of germ cell neoplasia. First, coexpression and nuclear localization of the BLIMP1/PRMT5 complex leads to histone H2A/H4 dimethylation which results in transcriptional silencing of genes responsible for somatic differentiation in PGCs. Upon differentiation to prespermatogonia, this complex is downregulated and the H2A/H4 marks are lost. Aberrant constitutive histone H2A/H4 arginine 3 dimethylation allows the cells to escape the regular differentiation program resulting in their persistence into adulthood. These cells eventually progress into IGCNU, displaying the H2A/H4R3me2s modification as well. Since the subcellular localization of PRMT5 excludes PRMT5-dependent histone H2A/H4 modification in IGCNU we propose that BLIMP1 might act in cooperation with PRMT7. This mechanism persists in seminoma where the H2A/H4R3me2s modifications can be observed which explains the undifferentiated nature of the tumor cells. Translocation of BLIMP1 into the cytoplasm leads to breakdown of histone H2A/H4 dimethylation and subsequently to the activation of the differentiation programs and therefore the conversion from IGCNU into a nonseminomatous germ cell tumors.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Sample Handling and Characterization</title><p>Formalin fixed, paraffin embedded testicular tissues from 46 patients with GCTs (20 seminomas, 15 embryonic carcinomas, 5 Teratomas, 3 yolk sac tumors and 3 choriocarcinomas were collected for this study from archives of Departments of Pathology of University Medical Centers Bonn. Adjacent testicular parenchyma containing IGCNU were studied in 15 cases[<xref ref-type="bibr" rid="B32">32</xref>]. All tumors were classified according to the WHO classification of tumors based on their histology by two independent pathologists. Fresh frozen samples of each of normal testicular tissues (n = 3), seminoma (n = 3), mixed germ cell tumors (n = 3), IGCNU (n = 5) and embryonal carcinomas (EC) (n = 3), as well as RNA extracts of TCam2 [<xref ref-type="bibr" rid="B33">33</xref>] and JKT-1[<xref ref-type="bibr" rid="B34">34</xref>] cell lines, of which TCam2 resembles a seminoma-like cell-line [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>], were additionally available for this study. Use of the tissue for scientific purposes was approved by the Institutional Regional Committee for Ethics.</p></sec><sec><title>RT-PCR and quantitative image analysis</title><p>Total RNA from at least three samples per tumor entity was extracted with TRIzol (Invitrogen, Karlsruhe, Germany) according to manufacturer's instruction. cDNA-syntesis was performed using SuperScript III reverse transcriptase (Invitrogen, Karlsruhe, Germany) and Oligo d(T)<sub>12&#x02013;18</sub>(Invitrogen, Karlsruhe, Germany) and 100 ng of total RNA according to manufacturers instructions. PCRs were carried out in triplicates with following Primers: <italic>BLIMP1 </italic>F: 5'-GGGTGCAGCCTTTATGAGTC-3'; <italic>BLIMP1 </italic>R: 5'-CCTTGTTCA TGCCCTGAGAT-3'; <italic>PRMT5 </italic>F: 5'TTGCCGGC TACTTTGAGACT-3'; <italic>PRMT5 </italic>R: 5'-AAGGCAGGA AAGCAGATTGA-3'; <italic>GAPDH</italic>-F: 5'-TGGTATCGTGGAA GGACTCATG AC-3; <italic>GAPDH R</italic>: 5'-ATGCC AGTGAGCTTCCCGTTCAGC-3'. (&#x003b2;-Act: 25 cycles BLIMP1 and PRMT5: 30 cycles). After agarose gel electrophoresis of the PCR-products band intensity was measured after RT-PCR with the image analysis software ImageJ 1.37 v (National Institutes of Health, USA, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/"/>) in triplicates and normalized to the according GAPDH band.</p></sec><sec><title>Co-Immunoprecipitation</title><p>Co-IP was performed with DYNABEADS<sup>&#x000ae; </sup>(Invitrogen, Carlsbad, USA) following manufacturers instructions. Immunopreciptation was performed with 1,5 &#x003bc;g anti-PRMT5 antibody (Chemicon, Temecula, USA) or anti-PRMT7 (Abcam, Cambrigde UK, 1:250). Western Blot with anti-BLIMP1 antibody followed (provided by H. M. J&#x000e4;ck).</p></sec><sec><title>Western Blot</title><p>For protein analysis Mini-PROTEAN Electrophoresis Cell and Mini Trans-Blot system was used (BioRad, Munich, Germany). Proteins were isolated using RIPA-buffer and prepared using standard protocol and finaly electrophoresed at 30 mA for 90 min. The gel was blotted onto a PVDF membrane in a BioRad blotting chamber overnight at 30 V at 4&#x000b0;C according to published protocols. After blocking in PBSTM (PBS, 0.1% v/v Tween 20, 5% low fat milk powder) primary antibodies (anti-BLIMP1 1:400 (kind gift from H. J&#x000e4;ck), anti-PRMT5 1:200, Chemicon International, USA) were incubated in PBSTM for 3 h at RT. The secondary antibodies (anti-rabbit-HRP, anti-mouse-HRP: DAKO, Hamburg, Germany) were diluted 1:2000. Finally the membrane was incubated in 2 ml PierceSuper Signal West Pico chemiluminescent substrate (Perbio, Bonn, Germany) and the signal was detected using Kodak X-Ray film (Kodak, Stuttgart, Germany).</p></sec><sec><title>Array Analysis</title><p>DNA Array Dataset used to analyze BLIMP1/PRMT5 expression in Seminoma, embryonal carcinoma, TCam2 and JKT1 were generated as described [<xref ref-type="bibr" rid="B32">32</xref>].</p></sec><sec><title>Immunohistochemistry</title><p>For immunohistochemistry on paraffin-embedded tissue, dewaxed, 4-&#x003bc;m thick tissue sections were microwave-pretreated in citrate-buffer. Primary antibodies to PRMT5 (Upstate, Charlottesville, VA, 1:500), PRMT7 (Abcam, Cambrigde UK, 1:250) BLIMP1 (provided by H-M. J&#x000e4;ck, University of Erlangen, Germany 1:500) and H2AR3me2s/H4R3me2s (Abcam, Cambridge, UK, 1:2000) were used for detection. Immunohistochemistry was performed using the DAKO EnVision-AEC Kit and manufacturers protocol (DAKO, Hamburg, Germany) as previously described [<xref ref-type="bibr" rid="B7">7</xref>]. Briefly, endogenous peroxidase was blocked for 5 min in 0.03% H<sub>2</sub>O<sub>2 </sub>(diluted in distilled water). Sections were washed in Tris-buffered saline (TBS; 0.05 M Tris and 0.85% NaCl, pH 7.6) and incubated with primary antibodies overnight at 4&#x000b0;C. Thereafter, a HRP-labeled polymer conjugated with a secondary antibody was applied (DAKO EnVision-AEC KIT). Pictures were taken using a Leica microscope fitted with a JVC digital camera (Leica, Bensheim, Germany). Figures were assembled using Adobe CS3 software package. Merge of pictures was performed using ImageJ (NIH, US).</p></sec></sec><sec><title>Authors' contributions</title><p>DE, KB, DN, AG performed experiments, AG, HMJ, AMM and LL contributed material, KS helped in analysis of the Immunohistochemistry. DE, KB and HS conceived the experiments. DE, KB, LL and HS wrote the manuscript. All authors have seen and approved the final version.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Gerrit Klemm and his Fotolab-Crew of the Foto- and Mediencenter and Wiebke Jeske for technical assistance. Grant support: This work was supported by the Deutsche Forschungsgemeinschaft (DFG 503/7 to H.S. and DFG 1265/1 to K.B.).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>F</given-names></name><name><surname>Hamid</surname><given-names>R</given-names></name><name><surname>Arya</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>HR</given-names></name></person-group><article-title>Testicular cancer: current update and controversies</article-title><source>Hosp Med</source><year>2002</year><volume>63</volume><fpage>615</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12422497</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGlynn</surname><given-names>KA</given-names></name><name><surname>Devesa</surname><given-names>SS</given-names></name><name><surname>Graubard</surname><given-names>BI</given-names></name><name><surname>Castle</surname><given-names>PE</given-names></name></person-group><article-title>Increasing incidence of testicular germ cell tumors among black men in the United States</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><fpage>5757</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16110032</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2005.08.227</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oosterhuis</surname><given-names>JW</given-names></name><name><surname>Looijenga</surname><given-names>LH</given-names></name></person-group><article-title>Testicular germ-cell tumours in a broader perspective</article-title><source>Nat Rev Cancer</source><year>2005</year><volume>5</volume><fpage>210</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15738984</pub-id><pub-id pub-id-type="doi">10.1038/nrc1568</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Berthelsen</surname><given-names>JG</given-names></name><name><surname>Giwercman</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name></person-group><article-title>Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma</article-title><source>Int J Androl</source><year>1987</year><volume>10</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">3034791</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2605.1987.tb00161.x</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Honecker</surname><given-names>F</given-names></name><name><surname>Stoop</surname><given-names>H</given-names></name><name><surname>de Krijger</surname><given-names>RR</given-names></name><name><surname>Chris Lau</surname><given-names>YF</given-names></name><name><surname>Bokemeyer</surname><given-names>C</given-names></name><name><surname>Looijenga</surname><given-names>LH</given-names></name></person-group><article-title>Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells</article-title><source>J Pathol</source><year>2004</year><volume>203</volume><fpage>849</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">15221945</pub-id><pub-id pub-id-type="doi">10.1002/path.1587</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TD</given-names></name><name><surname>Ulbright</surname><given-names>TM</given-names></name><name><surname>Eble</surname><given-names>JN</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name></person-group><article-title>OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>8544</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15623637</pub-id><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0688</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>K</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Jeske</surname><given-names>W</given-names></name><name><surname>Brehm</surname><given-names>R</given-names></name><name><surname>Steger</surname><given-names>K</given-names></name><name><surname>Wernert</surname><given-names>N</given-names></name><name><surname>Buttner</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><article-title>Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">16210381</pub-id><pub-id pub-id-type="doi">10.1093/humrep/dei325</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>Hanstein</surname><given-names>R</given-names></name><name><surname>Jorgensen</surname><given-names>N</given-names></name><name><surname>Graem</surname><given-names>N</given-names></name><name><surname>Vogt</surname><given-names>PH</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name></person-group><article-title>Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><fpage>1338</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">15105401</pub-id><pub-id pub-id-type="doi">10.1093/humrep/deh265</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Looijenga</surname><given-names>LH</given-names></name><name><surname>Stoop</surname><given-names>H</given-names></name><name><surname>de Leeuw</surname><given-names>HP</given-names></name><name><surname>de Gouveia Brazao</surname><given-names>CA</given-names></name><name><surname>Gillis</surname><given-names>AJ</given-names></name><name><surname>van Roozendaal</surname><given-names>KE</given-names></name><name><surname>van Zoelen</surname><given-names>EJ</given-names></name><name><surname>Weber</surname><given-names>RF</given-names></name><name><surname>Wolffenbuttel</surname><given-names>KP</given-names></name><name><surname>van Dekken</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>2244</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">12727846</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>AH</given-names></name><name><surname>Hartley</surname><given-names>L</given-names></name><name><surname>Parker</surname><given-names>K</given-names></name><name><surname>Ibrahim</surname><given-names>M</given-names></name><name><surname>Looijenga</surname><given-names>LH</given-names></name><name><surname>Pauchnik</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>CW</given-names></name><name><surname>Robb</surname><given-names>L</given-names></name></person-group><article-title>The pluripotency homeobox gene NANOG is expressed in human germ cell tumors</article-title><source>Cancer</source><year>2005</year><volume>104</volume><fpage>2092</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16206293</pub-id><pub-id pub-id-type="doi">10.1002/cncr.21435</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amit</surname><given-names>M</given-names></name><name><surname>Carpenter</surname><given-names>MK</given-names></name><name><surname>Inokuma</surname><given-names>MS</given-names></name><name><surname>Chiu</surname><given-names>CP</given-names></name><name><surname>Harris</surname><given-names>CP</given-names></name><name><surname>Waknitz</surname><given-names>MA</given-names></name><name><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name></person-group><article-title>Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture</article-title><source>Dev Biol</source><year>2000</year><volume>227</volume><fpage>271</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11071754</pub-id><pub-id pub-id-type="doi">10.1006/dbio.2000.9912</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Meier</surname><given-names>P</given-names></name><name><surname>Buchert</surname><given-names>M</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>PJ</given-names></name></person-group><article-title>Transcription factor AP-2 essential for cranial closure and craniofacial development</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>235</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8622765</pub-id><pub-id pub-id-type="doi">10.1038/381235a0</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>SHJ</given-names></name><name><surname>Gillis Ad</surname><given-names>JM</given-names></name><name><surname>van Gurp</surname><given-names>RJHLM</given-names></name><name><surname>Geijn</surname><given-names>G-JM van de</given-names></name><name><surname>de Boer</surname><given-names>M</given-names></name><name><surname>Hersmus</surname><given-names>R</given-names></name><name><surname>Saunders</surname><given-names>PTK</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Oosterhuis</surname><given-names>JW</given-names></name><name><surname>Looijenga</surname><given-names>LHJ</given-names></name></person-group><article-title>Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications</article-title><source>J Pathol</source><year>2008</year><volume>215</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18348160</pub-id><pub-id pub-id-type="doi">10.1002/path.2332</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrett</surname><given-names>RM</given-names></name><name><surname>Turnpenny</surname><given-names>L</given-names></name><name><surname>Eckert</surname><given-names>JJ</given-names></name><name><surname>O'Shea</surname><given-names>M</given-names></name><name><surname>Sonne</surname><given-names>SB</given-names></name><name><surname>Cameron</surname><given-names>IT</given-names></name><name><surname>Wilson</surname><given-names>DI</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>Hanley</surname><given-names>NA</given-names></name></person-group><article-title>The Early Human Germ Cell Lineage Does Not Express SOX2 During In Vivo Development or Upon In Vitro Culture</article-title><source>Biol Reprod</source><year>2008</year><pub-id pub-id-type="pmid">18199879</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>de Sousa Lopes</surname><given-names>SM</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name></person-group><article-title>Germ cell specification in mice</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>394</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17446386</pub-id><pub-id pub-id-type="doi">10.1126/science.1137545</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohinata</surname><given-names>Y</given-names></name><name><surname>Payer</surname><given-names>B</given-names></name><name><surname>O'Carroll</surname><given-names>D</given-names></name><name><surname>Ancelin</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>SC</given-names></name><name><surname>Obukhanych</surname><given-names>T</given-names></name><name><surname>Nussenzweig</surname><given-names>M</given-names></name><name><surname>Tarakhovsky</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Blimp1 is a critical determinant of the germ cell lineage in mice</article-title><source>Nature</source><year>2005</year><volume>436</volume><fpage>207</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">15937476</pub-id><pub-id pub-id-type="doi">10.1038/nature03813</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ancelin</surname><given-names>K</given-names></name><name><surname>Lange</surname><given-names>UC</given-names></name><name><surname>Hajkova</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name></person-group><article-title>Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells</article-title><source>Nat Cell Biol</source><year>2006</year><volume>8</volume><fpage>623</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">16699504</pub-id><pub-id pub-id-type="doi">10.1038/ncb1413</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaskell</surname><given-names>TL</given-names></name><name><surname>Esnal</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>LL</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Saunders</surname><given-names>PT</given-names></name></person-group><article-title>Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three Subpopulations</article-title><source>Biol Reprod</source><year>2004</year><pub-id pub-id-type="pmid">15317684</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giwercman</surname><given-names>A</given-names></name><name><surname>Marks</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>D</given-names></name><name><surname>Baumal</surname><given-names>R</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name></person-group><article-title>A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis</article-title><source>Apmis</source><year>1988</year><volume>96</volume><fpage>667</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">2843208</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Looijenga</surname><given-names>LH</given-names></name><name><surname>Hersmus</surname><given-names>R</given-names></name><name><surname>Gillis</surname><given-names>AJ</given-names></name><name><surname>Pfundt</surname><given-names>R</given-names></name><name><surname>Stoop</surname><given-names>HJ</given-names></name><name><surname>van Gurp</surname><given-names>RJ</given-names></name><name><surname>Veltman</surname><given-names>J</given-names></name><name><surname>Beverloo</surname><given-names>HB</given-names></name><name><surname>van Drunen</surname><given-names>E</given-names></name><name><surname>van Kessel</surname><given-names>AG</given-names></name><etal></etal></person-group><article-title>Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>290</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16397242</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2936</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>J</given-names></name><name><surname>Stoop</surname><given-names>H</given-names></name><name><surname>Gillis</surname><given-names>AJ</given-names></name><name><surname>Hersmus</surname><given-names>R</given-names></name><name><surname>van Gurp</surname><given-names>RJ</given-names></name><name><surname>Geijn</surname><given-names>GJ van de</given-names></name><name><surname>van Drunen</surname><given-names>E</given-names></name><name><surname>Beverloo</surname><given-names>HB</given-names></name><name><surname>Schneider</surname><given-names>DT</given-names></name><name><surname>Sherlock</surname><given-names>JK</given-names></name><etal></etal></person-group><article-title>Further characterization of the first seminoma cell line TCam-2</article-title><source>Genes Chromosomes Cancer</source><year>2008</year><volume>47</volume><fpage>185</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">18050305</pub-id><pub-id pub-id-type="doi">10.1002/gcc.20520</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eckert</surname><given-names>D</given-names></name><name><surname>Nettersheim</surname><given-names>D</given-names></name><name><surname>Heukamp</surname><given-names>LC</given-names></name><name><surname>Kitazawa</surname><given-names>S</given-names></name><name><surname>Biermann</surname><given-names>K</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>TCam-2 but not JKT-1 cells resemble seminoma in cell culture</article-title><source>Cell Tissue Res</source><year>2008</year><volume>331</volume><fpage>529</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">18008088</pub-id><pub-id pub-id-type="doi">10.1007/s00441-007-0527-y</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>J</given-names></name><name><surname>Stoop</surname><given-names>H</given-names></name><name><surname>Gillis</surname><given-names>AJ</given-names></name><name><surname>van Gurp</surname><given-names>RJ</given-names></name><name><surname>van Drunen</surname><given-names>E</given-names></name><name><surname>Beverloo</surname><given-names>HB</given-names></name><name><surname>Lau</surname><given-names>YF</given-names></name><name><surname>Schneider</surname><given-names>DT</given-names></name><name><surname>Sherlock</surname><given-names>JK</given-names></name><name><surname>Baeten</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>JKT-1 is not a human seminoma cell line</article-title><source>Int J Androl</source><year>2007</year><volume>30</volume><fpage>350</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">17705808</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2605.2007.00802.x</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonsalvez</surname><given-names>GB</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Ospina</surname><given-names>JK</given-names></name><name><surname>Boisvert</surname><given-names>FM</given-names></name><name><surname>Lamond</surname><given-names>AI</given-names></name><name><surname>Matera</surname><given-names>AG</given-names></name></person-group><article-title>Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins</article-title><source>J Cell Biol</source><year>2007</year><volume>178</volume><fpage>733</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">17709427</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200702147</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anne</surname><given-names>J</given-names></name><name><surname>Ollo</surname><given-names>R</given-names></name><name><surname>Ephrussi</surname><given-names>A</given-names></name><name><surname>Mechler</surname><given-names>BM</given-names></name></person-group><article-title>Arginine methyltransferase Capsuleen is essential for methylation of spliceosomal Sm proteins and germ cell formation in Drosophila</article-title><source>Development</source><year>2007</year><volume>134</volume><fpage>137</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">17164419</pub-id><pub-id pub-id-type="doi">10.1242/dev.02687</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonsalvez</surname><given-names>GB</given-names></name><name><surname>Rajendra</surname><given-names>TK</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Matera</surname><given-names>AG</given-names></name></person-group><article-title>The Sm-protein methyltransferase, dart5, is essential for germ-cell specification and maintenance</article-title><source>Curr Biol</source><year>2006</year><volume>16</volume><fpage>1077</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">16753561</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2006.04.037</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Durcova-Hills</surname><given-names>G</given-names></name><name><surname>Adams</surname><given-names>IR</given-names></name><name><surname>Barton</surname><given-names>SC</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>McLaren</surname><given-names>A</given-names></name></person-group><article-title>The role of exogenous fibroblast growth factor-2 on the reprogramming of primordial germ cells into pluripotent stem cells</article-title><source>Stem Cells</source><year>2006</year><volume>24</volume><fpage>1441</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16769760</pub-id><pub-id pub-id-type="doi">10.1634/stemcells.2005-0424</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>Y</given-names></name><name><surname>Zsebo</surname><given-names>K</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><article-title>Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture</article-title><source>Cell</source><year>1992</year><volume>70</volume><fpage>841</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1381289</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(92)90317-6</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Resnick</surname><given-names>JL</given-names></name><name><surname>Bixler</surname><given-names>LS</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Donovan</surname><given-names>PJ</given-names></name></person-group><article-title>Long-term proliferation of mouse primordial germ cells in culture</article-title><source>Nature</source><year>1992</year><volume>359</volume><fpage>550</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">1383830</pub-id><pub-id pub-id-type="doi">10.1038/359550a0</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>N</given-names></name><name><surname>Giwercman</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name></person-group><article-title>Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells</article-title><source>Histopathology</source><year>1993</year><volume>22</volume><fpage>373</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8514281</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2559.1993.tb00138.x</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>K</given-names></name><name><surname>Fink</surname><given-names>L</given-names></name><name><surname>Franke</surname><given-names>FE</given-names></name></person-group><article-title>Angiotensin-converting enzyme (CD143) in neoplastic germ cells</article-title><source>Lab Invest</source><year>1999</year><volume>79</volume><fpage>1425</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10576213</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosselman</surname><given-names>S</given-names></name><name><surname>Looijenga</surname><given-names>LH</given-names></name><name><surname>Gillis</surname><given-names>AJ</given-names></name><name><surname>van Rooijen</surname><given-names>MA</given-names></name><name><surname>Kraft</surname><given-names>HJ</given-names></name><name><surname>van Zoelen</surname><given-names>EJ</given-names></name><name><surname>Oosterhuis</surname><given-names>JW</given-names></name></person-group><article-title>Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>2884</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8610136</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.7.2884</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Gotoh</surname><given-names>A</given-names></name><name><surname>Kamidono</surname><given-names>S</given-names></name><name><surname>Kitazawa</surname><given-names>S</given-names></name></person-group><article-title>[Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2)]</article-title><source>Nippon Hinyokika Gakkai Zasshi</source><year>1993</year><volume>84</volume><fpage>1211</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8394948</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kinugawa</surname><given-names>K</given-names></name><name><surname>Hyodo</surname><given-names>F</given-names></name><name><surname>Matsuki</surname><given-names>T</given-names></name><name><surname>Jo</surname><given-names>Y</given-names></name><name><surname>Furukawa</surname><given-names>Y</given-names></name><name><surname>Ueki</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Establishment and characterization of a new human testicular seminoma cell line, JKT-1</article-title><source>Int J Urol</source><year>1998</year><volume>5</volume><fpage>282</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9624562</pub-id><pub-id pub-id-type="doi">10.1111/j.1442-2042.1998.tb00604.x</pub-id></citation></ref></ref-list></back></article> 